Transgenic rodent assay for quantifying male germ cell mutant frequency

Area of Science:

• Toxicology
• Genetics
• Reproductive Biology

Background:

• De novo mutations primarily occur in the male germline, potentially impacting offspring health.
• Traditional germ cell mutation assays are resource-intensive and rarely used in chemical risk assessment.
• Assessing germ cell mutagenicity is crucial for understanding heritable genetic risks.

Purpose of the Study:

• To describe a novel in vivo male germ cell mutation assay.
• To establish a method for assessing germ cell mutagenicity in chemical testing and risk assessment.
• To characterize stage-specific sensitivity of spermatogenic cells to mutagens.

Main Methods:

• Utilizes a transgenic rodent model with a reporter gene in germ cells.
• Employs an in vitro positive selection assay to detect in vivo induced mutations.
• Controls exposure duration, sampling time, and cell population for stage-specific analysis.

Main Results:

• The assay demonstrates superior sensitivity compared to traditional methods.
• It requires significantly fewer animals, time, and resources.
• The method allows for detailed characterization of mutagenic effects across different spermatogenic stages.

Conclusions:

• This transgenic rodent assay provides a sensitive and efficient tool for evaluating male germ cell mutagenicity.
• It aligns with recent OECD test guidelines, facilitating its adoption in regulatory settings.
• The assay enhances the assessment of potential adverse health outcomes in subsequent generations due to germline mutations.